The U.S. Food and Drug Administration (FDA), the US governmental authority responsible for regulating foods and medical products, authorized, on 16

Philip Morris International Inc. (PMI) (NYSE: PM) will host a live audio webcast at on Thursday, February 6, 2025, at 9:00 a.m. ET, to discuss its 2024 Fourth-Quarter and Full-Year financial results,

Zyn is manufactured by Swedish Match, which Philip Morris International acquired in a $16 billion deal in 2022. That year, Zyn shipped 238 million cans in the U.S. Philip Morris International forecasts that the total more than doubled in 2024. Zyn's growth comes as Philip Morris looks to transition more to smokeless products.

In a statement, the FDA said it has authorized the marketing and sale of Philip Morris International’s Zyn nicotine pouches. The pouches, which are placed between the lip and gum, are tobacco-free but contain nicotine. They come in different strengths and a variety of flavors such as citrus, coffee, peppermint and berry.

FDA authorizes Zyn nicotine pouches, citing public health benefits for adult smokers, despite concerns over flavored products' appeal to teens.

ZYN, the popular brand of flavored nicotine pouches, recently earned FDA authorization for reducing smoking, but some questions linger. Experts explain the efficacy and potential health risks of nicot

Analyst Lisa Lewandowski from Bank of America Securities maintained a Buy rating on Philip Morris (PM – Research Report) and keeping the price

These items have become popular in c-stores as traditional tobacco sales plunge, and their approval sets the stage for continued growth.

The U.S. Food and Drug Administration formally authorized Zyn nicotine pouches for sale after conducting an "extensive scientific review" about their safety.